Post-marketing safety concerns with elagolix: a disproportionality analysis of the FDA adverse event reporting system
Article in Expert Opinion on Drug Safety (May 2024)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
Article in Expert Opinion on Drug Safety (May 2024)
Article in European Journal of Clinical Pharmacology (December 2023)
Article in Frontiers in Pharmacology (September 2022)